Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Vision Medicals, a China-based gene-sequencing technology developer backed by Chinese Academy of Sciences, has raised RMB300m ($47m) in a series D round featuring internet and gaming group Tencent, DealStreetAsia reported today, citing a company statement. Boyu Capital, CDH Venture and Growth Capital, a vehicle for alternative asset management firm CDH, also took part in the…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
